Skip to content

A medical records based study for nano short peptide nutrition intervention on the prognosis of patients with novel coronavirus pneumonia (COVID-19)

A medical records based retrospective study on the effects of nano short peptide enteral nutrition intervention on the prognosis of patients with novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033609
Enrollment
Unknown
Registered
2020-06-07
Start date
2020-05-07
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

1:Nano short peptide enteral nutrition
2:hole protein enteral nutrition

Sponsors

Yichang Central People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
29 Years to 83 Years

Inclusion criteria

Inclusion criteria: Nano short peptide intervention group,those taking 2-3 bottles per person per day were recruited as the study subjects. 15 common patients (2 of 2 bottles, 13 of 3 bottles) were used as the treatment group, to study nutritional status and immune indicators.Whole egg white dry preparation group,those of light, severe, and critical types, or death, or those with non continuous intervention till discharge or with incomplete detection indexes were excluded. According to the sex and age of the treatment group, 51 common cases were matched as the control group.

Exclusion criteria

Exclusion criteria: Nano short peptide intervention group,12 patients were excluded from the study for the duration less than 2 days or their light or severe types.Whole egg white dry preparation group,those of light, severe, and critical types, or death, or those with non continuous intervention till discharge or with incomplete detection indexes were excluded.

Design outcomes

Primary

MeasureTime frame
prealbumin;lymphocyte;Length of stay;

Countries

China

Contacts

Public ContactZe-Lin Zhang

Yichang Central People's Hospital

421317343@qq.com+86 18671730555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026